Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Natural Products Detoxify Amyloid Oligomers and May Prevent Alzheimer's Disease

By LabMedica International staff writers
Posted on 21 Feb 2013
Molecular biologists studying the mechanisms that lead to the development of Alzheimer's disease have found that the process requires binding of amyloid-beta (A-beta) oligomers to neuron membrane prion protein (PrPC), a process that can be blocked by the natural compounds resveratrol and epigallocatechin gallate (EGCG).

Resveratrol is found primarily in the skin and seeds of grapes. More...
The amount found in grape skins varies with the grape cultivar, its geographic origin, and exposure to fungal infection. The amount of fermentation time a wine spends in contact with grape skins is an important determinant of its resveratrol content. Epidemiological and experimental reports have linked mild-to-moderate wine and/or grape consumption to a lowered risk of cardiovascular, cerebrovascular, and peripheral vascular diseases. EGCG is the most abundant catechin in tea and is a potent antioxidant that may have therapeutic applications in the treatment of many disorders. It is found in green tea but not black tea.

Investigators at the University of Leeds (United Kingdom) worked with an in vitro model of Alzheimer's disease. They used fluorescence microscopy to study the binding of A-beta oligomers to brain cells and examined the effect of exposure to resveratrol and EGCG on the binding process.

They reported in the February 5, 2013, online edition of the Journal of Biological Chemistry that A-beta oligomers bound preferentially to cells and neurons expressing PrPC. Binding of A-beta oligomers to cell surface PrPC was dependent on the integrity of cholesterol-rich lipid rafts. Lipid rafts are highly organized microdomains within the plasma membrane of cells, which are composed of a combination of glycosphingolipids and protein receptors. These specialized membrane microdomains compartmentalize cellular processes by serving as organizing centers for the assembly of signaling molecules, influencing membrane fluidity and membrane protein trafficking, and regulating neurotransmission and receptor trafficking. Lipid rafts are more ordered and tightly packed than the surrounding membrane, but float freely in the membrane bilayer.

Binding of A-beta oligomers to PrPC was inhibited by changes in the shape of the oligomers induced by exposure to either resveratrol or EGCG. A-beta oligomers that had been reshaped by these compounds failed to bind to PrPC and were no longer toxic to nerve cells.

"This is an important step in increasing our understanding of the cause and progression of Alzheimer's disease," said senior author Dr. Nigel Hooper professor of biochemistry at the University of Leeds. "It is a misconception that Alzheimer's is a natural part of ageing; it is a disease that we believe can ultimately be cured through finding new opportunities for drug targets like this."

The investigators formed amyloid balls in a test tube and added them to human and animal brain cells. Prof. Hooper said, "When we added the extracts from red wine and green tea, which recent research has shown to reshape amyloid proteins, the amyloid balls no longer harmed the nerve cells. We saw that this was because their shape was distorted, so they could no longer bind to prion and disrupt cell function. We also showed, for the first time, that when amyloid balls stick to prion, it triggers the production of even more amyloid, in a deadly vicious cycle. I am certain that this will increase our understanding of Alzheimer's disease even further, with the potential to reveal yet more drug targets."

Related Links:
University of Leeds



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.